NAD+ IV Therapy in Delhi — Skin Rejuvenation, Cost, Potential Benefits, Safety & Evidence
Medically reviewed by: Dr Reema Arora, MBBS, MSc Facial Aesthetics (UK)
Clinic: The Face Clinic, Hauz Khas, South Delhi, New Delhi, India
Last medically reviewed: October 2026
NAD+ IV therapy has attracted growing interest in skin rejuvenation, healthy ageing, energy and wellness. NAD+, or nicotinamide adenine dinucleotide, is a naturally occurring coenzyme with established roles in cellular metabolism, redox reactions and cellular signalling.
However, an important distinction is often lost in discussions about NAD+ treatment: the biological importance of NAD+ does not establish that giving NAD+ intravenously produces clinically meaningful anti-ageing, skin-rejuvenation, cognitive or wellness benefits.
Current direct clinical evidence for intravenous NAD+ itself remains limited.
At The Face Clinic in Hauz Khas, South Delhi, NAD+ IV therapy is therefore approached conservatively. Treatment may be considered for appropriately selected individuals after medical assessment and discussion of the evidence, uncertainties, possible risks and alternatives.
It is not presented as a proven treatment for skin ageing, fatigue, longevity or any medical disease.
NAD+ IV therapy at The Face Clinic typically costs ₹15,000–₹30,000 per session, depending on the prescribed protocol, infusion duration and clinical monitoring requirements.
NAD+ IV Therapy at a Glance
Question | Current position |
What is NAD+ IV therapy? | Intravenous administration of nicotinamide adenine dinucleotide |
Why is NAD+ scientifically important? | NAD+ has established roles in cellular metabolism, redox biology and signalling |
Is IV NAD+ proven to rejuvenate skin? | No — direct clinical evidence is currently insufficient |
Is NAD+ IV therapy a proven anti-ageing treatment? | No |
Is IV NAD+ proven to improve energy or cognition? | Not through robust clinical-outcomes evidence |
Is IV NAD+ equivalent to oral NMN or NR research? | No — the interventions and evidence bases differ |
Is an established treatment course available? | No universally validated schedule currently exists |
Is medical screening appropriate? | Yes |
Typical cost at The Face Clinic | ₹15,000–₹30,000 per session |
What Is NAD+ IV Therapy?
NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme naturally present within human cells. It participates in essential biochemical processes including cellular energy metabolism, oxidation-reduction reactions and intracellular signalling.
NAD+ IV therapy, also referred to as an NAD drip, NAD+ drip, NAD infusion or NAD+ infusion therapy, administers NAD+ intravenously through a controlled infusion.
Intravenous administration places the administered substance directly into the systemic circulation without first passing through gastrointestinal absorption.
That fact should not, however, be confused with proof of better clinical outcomes.
Direct intravenous administration does not by itself establish that NAD+:
- reaches relevant tissues intact in clinically meaningful amounts;
- produces greater intracellular NAD+ availability;
- improves ageing-related outcomes;
- rejuvenates the skin;
- increases energy;
- improves cognition; or
- is clinically superior to oral NAD+ precursor strategies.
At The Face Clinic, consideration of NAD+ IV therapy begins with the patient’s objective and medical assessment rather than with selection from a predetermined IV-drip menu.
What Does NAD+ Do in the Body?
NAD+ has well-established biological functions.
It is involved in:
- cellular energy metabolism;
- oxidation-reduction reactions;
- mitochondrial biology;
- cellular signalling;
- enzymes involved in DNA repair;
- cellular stress-response pathways; and
- multiple metabolic processes required for normal cell function.
These functions help explain why NAD metabolism has become an important area of ageing, metabolic and translational research.
Does NAD+ Decline With Age?
The relationship between NAD+ and ageing is more complex than the frequently repeated claim that “NAD+ simply declines as we get older.”
Changes in NAD-related metabolism have been observed in experimental and human research, but findings may vary according to:
- the tissue being studied;
- metabolic health;
- disease burden;
- population characteristics; and
- the method used to measure NAD-related compounds.
Recent human research has also challenged the assumption that whole-blood NAD+ concentrations inevitably fall as part of healthy ageing alone.
Reduced NAD+ should therefore not automatically be assumed in an otherwise healthy person simply because of age.
Biological Importance Does Not Equal Treatment Effectiveness
This distinction is fundamental when evaluating NAD+ IV therapy.
Demonstrating that NAD+ participates in cellular metabolism does not demonstrate that intravenous NAD+ clinically improves:
- skin hydration;
- skin texture;
- fine lines or wrinkles;
- elasticity;
- pigmentation;
- fatigue;
- cognitive performance;
- longevity; or
- general wellness.
A plausible biological mechanism provides a reason to study an intervention.
It is not the same as proving a clinically meaningful outcome.
What Are the Potential Benefits of NAD+ IV Therapy — and What Is Actually Proven?
Patients researching NAD+ IV therapy benefits will commonly encounter claims involving energy, cognitive performance, recovery, skin rejuvenation, anti-ageing and longevity.
These claims need to be separated according to the quality of evidence behind them.
What Is Well Established?
NAD+ itself is biologically important.
Its involvement in cellular metabolism, redox reactions and cellular signalling is well documented.
What Has Human NAD+ Research Shown?
Much of the human clinical research concerning NAD augmentation has involved NAD+ precursors such as:
- nicotinamide riboside (NR); and
- nicotinamide mononucleotide (NMN).
Some studies demonstrate changes in NAD-related biochemical markers following these interventions.
However, a change in a biomarker does not necessarily mean that a patient experiences a meaningful improvement in health, symptoms, physical function or visible ageing.
What Remains Unproven for Intravenous NAD+?
Current evidence does not establish that NAD+ IV therapy reliably:
- rejuvenates ageing skin;
- improves wrinkles;
- improves skin elasticity;
- increases skin hydration;
- increases energy in otherwise healthy individuals;
- improves cognitive performance;
- prevents age-related disease;
- extends lifespan;
- produces clinically meaningful anti-ageing effects;
- accelerates recovery; or
- improves general wellness.
The optimal IV dose, treatment interval, number of sessions and long-term safety of repeated NAD+ IV administration also remain insufficiently established.
NAD+ IV Therapy for Skin Rejuvenation — What Does the Evidence Show?
The relationship between NAD biology, cellular metabolism and ageing has created understandable interest in NAD+ for skin health and skin rejuvenation.
Research into NAD-related pathways provides a scientific rationale for studying this relationship.
That is not the same as demonstrating that an NAD+ IV drip has been clinically proven to rejuvenate human skin.
At present, there is insufficient high-quality clinical evidence showing that intravenous NAD+ reliably improves:
- skin hydration;
- fine lines or wrinkles;
- skin elasticity;
- pigmentation;
- skin texture;
- visible collagen-related ageing; or
- overall visible skin rejuvenation.
For patients whose primary concern is skin quality, dehydration, fine lines, pigmentation, laxity or structural facial ageing, treatment should begin with identifying the cause of the visible change.
Depending on the concern, a treatment with more direct skin-specific evidence may be more appropriate.
For example, patients primarily concerned with hydration, smoothness or early skin-quality change can read more about skin booster treatment in Delhi.
NAD+ IV therapy should therefore not replace established dermatological or aesthetic treatment when another treatment is better supported for the patient’s specific concern.
At The Face Clinic, NAD+ IV therapy may be discussed as an adjunctive option where appropriate, but the limitations of the evidence should form part of that discussion.
NAD+ Biology vs NAD+ IV Therapy — Why the Difference Matters
One of the most important sources of confusion surrounding NAD+ treatment is the assumption that because NAD+ performs important biological functions, administering NAD+ intravenously must enhance those functions clinically.
That conclusion has not been established.
Evidence question | Current position |
Is NAD+ biologically important? | Yes |
Is NAD+ involved in cellular energy metabolism? | Yes |
Can some NAD-related interventions alter NAD-related biomarkers? | Yes |
Does this prove meaningful clinical benefits from IV NAD+? | No |
Are skin-rejuvenation benefits from IV NAD+ established? | No |
Are anti-ageing benefits from IV NAD+ established? | No |
Is IV NAD+ proven superior to oral NMN or NR? | No |
Is an optimal IV NAD+ dose established? | No |
Is an evidence-based maintenance schedule established? | No |
Is long-term repeated-use safety adequately established? | Not currently |
This distinction helps patients separate established NAD biology from emerging NAD+ IV therapy claims.
What Does the Clinical Evidence Say About NAD+ IV Therapy?
The evidence surrounding NAD augmentation varies substantially according to the molecule, route of administration, patient population and outcome being studied.
A 2026 systematic review of NAD+ supplementation and clinical evidence examined human and preclinical studies involving NAD-related interventions.
Human clinical research primarily involved NAD+ precursors such as NR and NMN.
While some interventions demonstrated changes in NAD-related biochemical markers, clinically meaningful functional, metabolic and other outcomes were heterogeneous and often absent or dependent on individual study endpoints.
Most importantly for patients considering an infusion, the systematic review identified no eligible clinical-outcomes trials evaluating intravenous or intramuscular NAD+ itself for anti-ageing or wellness indications.
A separate 2026 review of intravenous NAD+ and NAD+ precursors similarly found that the available human evidence for IV NAD+ remains preliminary.
Existing research consists largely of:
- small studies;
- uncontrolled investigations;
- observational data;
- limited pharmacokinetic work;
- short follow-up periods; and
- biomarker rather than validated clinical-outcome measurements.
The available evidence therefore does not currently establish:
- clinical effectiveness;
- durability of any benefit;
- an optimal dose;
- an optimal treatment schedule; or
- long-term repeated-use safety.
What Does This Mean for Patients?
The evidence supports continued scientific interest in NAD-related biology.
It does not currently support presenting NAD+ IV therapy as an established treatment for anti-ageing, skin rejuvenation, cognitive enhancement, longevity or general wellness.
At The Face Clinic, this uncertainty forms part of the consultation rather than being omitted from it.
NAD+ IV Therapy vs Oral NMN or NR
Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are NAD+ precursors that have been studied as strategies for influencing NAD-related metabolism.
Evidence involving oral NR or NMN should not simply be transferred to intravenous NAD+.
Likewise, the fact that IV administration bypasses gastrointestinal absorption should not be interpreted as evidence that IV NAD+ is clinically superior.
Different molecules and routes of administration can have different:
- pharmacokinetics;
- metabolic pathways;
- dosing considerations;
- safety profiles; and
- clinical evidence.
Current research does not establish that IV NAD+ is clinically superior to oral NR or NMN for anti-ageing, skin, energy or wellness outcomes.
NAD+ IV Therapy vs Skin Boosters
NAD+ IV therapy and skin boosters are fundamentally different interventions.
Skin boosters are injected locally into the skin and are selected primarily for specific skin-quality concerns such as hydration, smoothness and selected fine textural changes, depending on the formulation used.
NAD+ IV therapy is administered systemically and does not currently have comparable clinical evidence establishing a direct skin-rejuvenation effect.
For a patient whose principal objective is improved hydration or skin texture, the useful question is therefore not simply which treatment is newer or more widely discussed.
It is:
Which treatment has evidence relevant to the particular skin concern being treated?
Patients interested specifically in injectable hydration and skin-quality treatment can read the clinic’s guide to skin booster treatment in Delhi.
NAD+ IV Therapy vs PDRN and Regenerative Injectables
NAD+ IV therapy should also be distinguished from PDRN and other injectable treatments increasingly discussed within regenerative aesthetics.
PDRN is administered locally and has a different formulation, biological rationale and emerging dermatological evidence base.
The two approaches are therefore not interchangeable.
Terms such as “regenerative,” “cellular” or “bio-repair” should also not be treated as proof that a treatment produces clinically meaningful rejuvenation.
At The Face Clinic, selection begins with the indication:
- What is the patient’s actual concern?
- What biological process is being targeted?
- What clinical evidence supports that intervention?
- Is treatment medically appropriate?
For more detailed information on this treatment category, see PDRN treatment in Delhi.
NAD+ IV Therapy vs Other IV Drip Treatments
Different IV therapies contain different substances and should not be treated as interchangeable wellness drips.
NAD+, glutathione, vitamin C, electrolytes and other substances have different:
- biological roles;
- evidence bases;
- dosing considerations;
- contraindications;
- potential adverse effects; and
- appropriate clinical uses.
Similarly, combining several substances within a single infusion does not automatically produce better outcomes.
Patients considering NAD+ within a wider IV treatment programme should therefore undergo assessment rather than selecting an infusion according to a marketing name or package.
The clinic’s wider approach to intravenous treatment is explained in the guide to doctor-led IV therapy in Delhi.
NAD+ IV Therapy Cost in Delhi, India
At The Face Clinic, NAD+ IV therapy cost in Delhi typically ranges from ₹15,000–₹30,000 per session.
The final treatment cost can vary according to:
- the NAD+ protocol prescribed;
- amount administered where clinically relevant;
- infusion duration;
- medical assessment;
- monitoring requirements;
- accompanying treatment where clinically justified; and
- whether additional investigations are considered appropriate.
Treatment price should not determine whether NAD+ IV therapy is clinically appropriate.
Suitability should be considered first, followed by a transparent explanation of the proposed protocol, expected treatment duration, monitoring requirements and final cost.
For patients exploring the clinic’s wider intravenous treatment options, see the guide to doctor-led IV therapy in Delhi.
Is a Package of NAD+ IV Sessions Necessary?
There is currently no universally established evidence-based number of NAD+ IV sessions for:
- skin rejuvenation;
- anti-ageing;
- energy enhancement;
- cognitive enhancement; or
- general wellness.
Patients should therefore be cautious about assuming that a predetermined treatment package or fixed maintenance schedule is scientifically necessary.
Any recommendation for repeat treatment should have an individual clinical rationale.
Who May Be Considered for NAD+ IV Therapy?
There is currently no universally validated patient profile for NAD+ IV treatment for anti-ageing, skin rejuvenation or general wellness.
A consultation may nevertheless be appropriate for someone who wants to understand the intervention, its evidence and whether it is reasonable to consider in their individual circumstances.
Importantly:
Consultation does not mean NAD+ IV therapy will automatically be recommended.
Particular care is appropriate where NAD+ treatment is being sought for symptoms such as:
- persistent fatigue;
- reduced exercise tolerance;
- unexplained weakness;
- cognitive symptoms;
- poor concentration;
- sleep disturbance; or
- other systemic symptoms.
These symptoms can have many potential causes.
Appropriate medical evaluation should take priority over assuming that an NAD+ deficiency exists or that an NAD+ infusion is required.
Medical Screening Before NAD+ IV Therapy
NAD+ IV therapy is an intravenous medical procedure and should not be treated as a routine spa service.
Before treatment, assessment may include review of:
- the reason NAD+ therapy is being requested;
- relevant medical conditions;
- medications and supplements;
- allergies;
- previous reactions to IV treatments;
- pregnancy or breastfeeding;
- cardiovascular considerations;
- kidney function or renal conditions;
- fluid-balance considerations;
- relevant investigations where clinically indicated; and
- whether another diagnosis or treatment should take priority.
Where the symptoms being treated warrant further evaluation, appropriate medical investigation or referral should occur before elective IV therapy.
What Happens During an NAD+ IV Infusion?
Where NAD+ therapy is considered appropriate, treatment is administered intravenously in a monitored clinical environment.
Step 1 — Medical Consultation and Screening
The consultation establishes:
- why NAD+ IV therapy is being considered;
- relevant symptoms or treatment goals;
- medical history;
- current medications and supplements;
- possible contraindications; and
- whether further assessment is required.
Step 2 — Evidence and Expectation Discussion
The rationale for treatment, limitations of current evidence, potential risks, realistic expectations and possible alternatives are discussed.
Patients should have an opportunity to understand what is established scientifically and what remains uncertain.
Step 3 — Individual Protocol Planning
There is no evidence-based universal NAD+ drip protocol that can be assumed appropriate for every patient.
Where treatment proceeds, the protocol should therefore be determined individually rather than selected automatically from a standard wellness-drip menu.
Step 4 — IV Administration
A cannula is inserted using appropriate sterile technique and the infusion is administered at a controlled rate.
NAD+ administration may require adjustment of infusion rate according to protocol and individual tolerance.
Step 5 — Monitoring
The patient is monitored during administration for tolerance and potential reactions.
Step 6 — Post-Treatment Advice
Appropriate aftercare and any clinically indicated follow-up are explained before the patient leaves the clinic.
NAD+ IV Therapy Safety and Possible Side Effects
NAD+ IV therapy should not simply be described as “safe.”
All intravenous treatments carry potential risks, and robust long-term safety data for repeated IV NAD+ administration remain limited.
Reported short-term symptoms associated with intravenous NAD-related administration have included:
- nausea;
- flushing or warmth;
- abdominal or muscular cramping;
- headache or discomfort;
- chest discomfort; and
- intolerance associated with faster administration.
General risks associated with intravenous treatment can also include:
- bruising;
- vein irritation;
- infection;
- infiltration or extravasation;
- vasovagal reactions;
- fluid-related complications in susceptible individuals;
- infusion-related reactions; and
- uncommon but potentially more significant complications.
The absence of a complication following an individual infusion does not establish long-term safety for repeated treatment.
What Should Patients Searching for “Safe NAD+ IV Therapy in Delhi” Look For?
No intravenous treatment should be presented as completely risk-free.
More meaningful factors include:
- qualified medical assessment;
- appropriate patient selection;
- transparent discussion of evidence;
- contraindication screening;
- sterile IV technique;
- appropriate infusion rate;
- monitoring during treatment;
- ability to recognise and manage adverse reactions; and
- clear follow-up arrangements.
These considerations provide more useful information than simply describing a treatment as “safe.”
Can NAD+ IV Therapy Be Combined With Skin Boosters, PDRN or Other Treatments?
The fact that two treatments act through different biological mechanisms does not automatically mean that combining them produces a better result.
When combination treatment is considered, each intervention should have its own clear indication.
Treatment planning should consider:
- the patient’s primary concern;
- the evidence supporting each proposed treatment;
- whether the treatments address different problems;
- possible treatment-related inflammation;
- recovery requirements;
- sequencing; and
- whether adding another intervention materially improves the treatment rationale.
For example, a patient whose principal objective is skin hydration or texture may be better served by first assessing whether a skin booster treatment in Delhi or a regenerative skin-quality treatment such as PDRN treatment in Delhi is more directly relevant to the concern.
More treatment is not automatically better treatment.
How The Face Clinic Approaches NAD+ IV Therapy
At The Face Clinic, NAD+ IV therapy follows an assessment-first rather than package-first approach.
NAD+ treatment is not presented as:
- a cure;
- a detoxification treatment;
- a guaranteed energy treatment;
- a proven anti-ageing intervention;
- a treatment proven to rejuvenate skin;
- a longevity treatment;
- a replacement for medical diagnosis; or
- an intervention with predictable results.
Instead, the consultation focuses on five questions.
1. What Is the Patient Actually Trying to Improve?
A symptom or skin concern should first be understood before selecting an intervention.
2. Does the Concern Require Medical Investigation?
Symptoms such as persistent fatigue, cognitive change or unexplained weakness should not automatically be attributed to NAD biology.
3. What Does the Current Evidence Support?
Established NAD biology is separated from clinical evidence for intravenous NAD+ treatment.
4. What Remains Uncertain?
Important uncertainties include:
- clinical effectiveness;
- clinically meaningful outcomes;
- optimal dosing;
- treatment frequency;
- maintenance schedules;
- durability of benefit; and
- long-term repeated-use safety.
5. Is There a Better-Supported Alternative?
Where another treatment or medical approach has more direct evidence for the patient’s actual concern, that should form part of the discussion.
Why Doctor-Led Assessment Matters for NAD+ IV Therapy
The important clinical question is not simply whether NAD+ IV therapy is available.
It is whether intravenous treatment is appropriate for the individual considering it.
Doctor-led assessment allows the following to be evaluated before an infusion is administered:
- treatment objective;
- medical symptoms;
- health history;
- current medications;
- contraindications;
- procedural risk;
- evidence limitations; and
- alternative treatment options.
At The Face Clinic in Hauz Khas, South Delhi, NAD+ IV therapy is considered within this medical framework rather than as an automatic wellness-drip purchase.
Patients considering other infusion treatments can also review the clinic’s broader approach to doctor-led IV therapy in Delhi.
Frequently Asked Questions About NAD+ IV Therapy
Is NAD+ IV Therapy Scientifically Proven?
NAD+ has scientifically established biological functions, but evidence establishing specific clinical benefits from intravenous NAD+ remains limited.
Current evidence does not establish IV NAD+ as a proven anti-ageing, skin-rejuvenation, cognitive-enhancement or wellness treatment.
Does NAD+ IV Therapy Rejuvenate the Skin?
There is currently insufficient high-quality clinical evidence demonstrating that NAD+ IV therapy reliably improves wrinkles, hydration, elasticity, pigmentation or other visible signs of skin ageing.
Research into NAD biology creates scientific interest in the subject, but biological plausibility should not be presented as proof of cosmetic benefit.
What Are the Benefits of NAD+ IV Therapy?
Claims discussed online commonly include:
- increased energy;
- improved cognition;
- faster recovery;
- anti-ageing effects;
- improved skin quality; and
- longevity benefits.
These proposed outcomes have not been established through robust clinical-outcomes evidence for intravenous NAD+ itself.
Patients should therefore distinguish potential or theoretical benefits from clinically proven outcomes.
Does NAD+ IV Therapy Increase Energy?
NAD+ is involved in cellular energy metabolism.
That biological role does not prove that an NAD+ infusion reliably increases subjective energy or treats fatigue.
Persistent fatigue should be medically assessed because it can have numerous underlying causes.
Is NAD+ IV Therapy an Anti-Ageing Treatment?
It should not currently be regarded as an established anti-ageing treatment.
NAD metabolism is an important area of ageing research, but clinically meaningful anti-ageing outcomes from IV NAD+ have not been adequately demonstrated in human trials.
Does NAD+ IV Therapy Improve Longevity?
There is currently no high-quality clinical evidence demonstrating that IV NAD+ extends human lifespan or prevents ageing-related disease.
Is IV NAD+ Better Than Oral NMN or NR?
Current evidence does not establish clinical superiority of intravenous NAD+ over oral NAD+ precursors for anti-ageing, skin, energy or wellness outcomes.
They are different interventions and should be evaluated according to their own evidence.
How Many NAD+ IV Sessions Are Needed?
There is currently no universally validated NAD+ IV treatment schedule for anti-ageing, skin rejuvenation or general wellness.
A predetermined multi-session package should therefore not be described as scientifically required.
How Quickly Will I See Results After NAD+ IV Therapy?
There is no reliably established timeframe for cosmetic or general wellness benefits from IV NAD+ therapy.
Individual subjective experiences may vary, but they should not be presented as evidence of a predictable clinical response.
Is NAD+ IV Therapy Safe?
Short-term IV administration has been described in limited human research, but robust long-term safety data for repeated NAD+ IV treatment remain lacking.
Potential treatment reactions and general IV-related risks should be discussed before treatment.
Can NAD+ IV Therapy Be Combined With Skin Boosters, PDRN or Other Treatments?
Potential combination treatment should be based on clearly identified treatment indications rather than assuming that multiple interventions produce greater benefit.
Where a combination is considered, evidence, treatment sequencing, recovery requirements and potential risks should be reviewed individually.
Is NAD+ IV Therapy Suitable for Indian Skin?
Skin colour or ethnicity alone does not establish suitability for systemic NAD+ IV therapy.
Where the patient’s concern involves pigmentation, texture, dehydration, laxity or another visible skin change, the underlying skin concern should first be assessed so treatment can be directed at the actual indication.
What Does NAD+ IV Therapy Cost in Delhi?
At The Face Clinic, NAD+ IV therapy generally costs ₹15,000–₹30,000 per session.
The final cost depends on factors including the prescribed NAD+ protocol, infusion duration, medical assessment and monitoring requirements.
Treatment recommendations and final pricing are discussed after suitability has been assessed.
Patients interested in the clinic’s broader intravenous treatment programme can also review the IV therapy in Delhi treatment guide.
What Should I Look for When Choosing an NAD+ IV Therapy Clinic in Delhi?
Useful considerations include:
- who is medically responsible for treatment;
- whether medical history and medications are reviewed;
- whether suitability is assessed before treatment;
- whether the evidence and its limitations are explained;
- how IV procedures are monitored;
- how sterility is maintained;
- whether adverse reactions can be recognised and managed; and
- what follow-up arrangements are available.
Price or a long list of advertised “benefits” should not be the sole basis for selecting an IV therapy provider.
Considering NAD+ IV Therapy in Delhi?
If you are considering an NAD+ drip, the first question should not simply be:
Which dose or package should I buy?
A useful medical consultation should establish:
- what you are hoping to improve;
- whether symptoms require investigation first;
- what current evidence actually supports;
- what remains uncertain;
- whether an alternative treatment is better supported;
- what the potential risks are; and
- whether proceeding is reasonable for you.
At The Face Clinic, Hauz Khas, South Delhi, NAD+ IV therapy is considered only after doctor-led assessment and discussion of current evidence.
A consultation does not create an obligation to undergo treatment, and NAD+ IV therapy may not be recommended where another approach is more appropriate.
Patients interested in the clinic’s wider intravenous treatment approach can explore doctor-led IV therapy in Delhi.
The Face Clinic — Dr Reema Arora
LGF, C-36, Chaudhary Dilip Singh Marg
Hauz Khas Market
New Delhi – 110016
Clinic Hours: Monday–Saturday, 10 AM–6 PM
Phone: +91 99580 73900
About the Medical Reviewer
Dr Reema Arora is Founder and Medical Director of The Face Clinic in Hauz Khas, South Delhi, with more than 20 years of experience in facial aesthetics.
She is a medical graduate of St. John’s Medical College, Bangalore, and holds an MSc in Facial Aesthetics from the UK.
Dr Reema previously served as Medical Head – Facial Aesthetics at Allergan India and has been extensively involved in physician education and training in injectable and non-surgical aesthetic medicine.
Her approach at The Face Clinic emphasises:
- appropriate patient selection;
- medical assessment;
- anatomical understanding;
- realistic expectations;
- transparent discussion of limitations; and
- evidence-informed treatment planning.
You can learn more about Dr Reema Arora and The Face Clinic.
Clinical Evidence and References
2026 Systematic Review of NAD+ Supplementation
NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence
Gallagher C, Emmanuel OO. Ageing Research Reviews. 2026;116:103057.
Why it matters: The review evaluated human and preclinical NAD-related interventions. Human research primarily involved NR and NMN, while no eligible clinical-outcomes trials of intravenous or intramuscular NAD+ itself were identified for anti-ageing or wellness indications.
2026 Review of Intravenous NAD+ Therapy
Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine
Alangari A, Arif J, Al Qureshah F, Alkhodairy F. Frontiers in Aging. Published September 10, 2026.
Why it matters: The review concluded that current human IV NAD+ evidence remains preliminary and methodologically limited, with insufficient evidence to establish routine clinical effectiveness, durability of benefit, optimal dosing or long-term safety.
Medical Information Disclaimer
This page is intended for patient education.
It should not be interpreted as establishing that NAD+ IV therapy is effective for any specific medical, cosmetic, anti-ageing or wellness indication.
Scientific understanding of NAD biology and NAD-augmenting interventions continues to develop. Evidence relating specifically to intravenous NAD+ remains limited.
Medical symptoms should be appropriately assessed rather than self-treated with an elective IV infusion.
Treatment suitability can only be determined after individual medical assessment.
